News Highlights
Bloomberg: FTC Caught in Balancing Act With Pharmacy Benefit Manager Probe
July 29, 2022
“There’s this narrative out there, this assumption, that community pharmacies are closing and they’re closing in escalating rates,” PCMA President…
Forbes: Regulatory Attacks On Pharmacy Benefit Managers Will Not Lower Drug Prices
July 13, 2022
The market for prescription drugs is exceedingly complicated, in part because there are many disparate actors……
The Wall Street Journal: In Defense of Pharmacy Benefit Managers
July 12, 2022
Washington is a town not known for bipartisan agreement. But its swarms of drug-company lobbyists appear to have united both…
June 06, 2022
In my experience, PBMs do not contribute to the rising costs of prescription drugs—in fact, they do the exact opposite….
POLITICO Q&A: PCMA Chief Executive JC Scott
June 02, 2022
JC Scott and PCMA's top lobbyist Kristin Bass talk about the criticism facing the PBM industry, how to break through…
PBMs Under Fire at Senate Hearing
May 05, 2022
"The PBM industry is the only stakeholder in the chain dedicated to seeking lower costs, and we are proud to…
Washington DC’s 500 Most Influential People
May 03, 2022
JC Scott, Pharmaceutical Care Management Association, President and CEO Scott worked to include a repeal of the last administration’s prescription-drug…
Part D plans have extra time to prep to apply price concessions at the point of sale
April 29, 2022
"This extra year will help to reduce disruptions to Medicare beneficiaries by allowing Part D plans time to adjust their…
Profit Pump: 100 years after first patient uses insulin, out-of-pocket costs continue to climb
April 25, 2022
“We believe the key to reducing drug costs is increasing competition, including for insulin products," said the Pharmaceutical Care Management…
Drugmakers are the ones that control the cost of insulin
April 20, 2022
Drug manufacturers have leveraged limited competition in the insulin market to increase the list price of insulin products over the…
Bipartisan lawmakers push for ending insulin rebates in drug prices bill
April 12, 2022
The provision to target rebates drew pushback from the Pharmaceutical Care Management Association, which represents the PBM industry. The priorities…
Mayo-backed nonprofit Civica Rx plans to make low-cost insulin starting in 2024
March 27, 2022
Greg Lopes, a spokesman for the Pharmaceutical Care Management Association, said PBMs believe the key to lowering costs for insulin,…
